See Local News
Get Balanced News From Your U.S. State.
See Local News
See all locals

In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease

Posted on AllSides December 8th, 2023
From The Center
CHRISTINE KAO/STAT

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

Read full story
https://www.statnews.com/2023/12/08/fda-approves-casgevy-crispr-based-medicine-for-treatment-of-sickle-cell-disease/

More News about Public Health from the Left, Center and Right

From the Left

From the Center

From the Right